Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
14.67
-1.13 (-7.15%)
At close: Oct 22, 2026, 4:00 PM EDT
14.40
-0.27 (-1.84%)
Pre-market: Oct 23, 2026, 4:02 AM EDT

Iambic Therapeutics Statistics

Total Valuation

IAM has a market cap or net worth of $695.37 million. The enterprise value is $492.72 million.

Market Cap695.37M
Enterprise Value 492.72M

Important Dates

The next estimated earnings date is Thursday, November 19, 2026, after market close.

Earnings Date Nov 19, 2026
Ex-Dividend Date n/a

Share Statistics

IAM has 47.40 million shares outstanding.

Current Share Class 47.40M
Shares Outstanding 47.40M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 7.41%
Owned by Institutions (%) n/a
Float 4.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 38.10
Forward PS n/a
PB Ratio 4.31
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 27.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.03.

Current Ratio 4.59
Quick Ratio 4.51
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7,706.62

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -53.13%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee $106,731
Profits Per Employee -$551,146
Employee Count 171
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, IAM has paid $47,000 in taxes.

Income Tax 47,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 1,553,523

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, IAM had revenue of $18.25 million and -$94.25 million in losses. Loss per share was -$4.27.

Revenue18.25M
Gross Profit -83.49M
Operating Income -100.19M
Pretax Income -94.20M
Net Income -94.25M
EBITDA -98.81M
EBIT -100.19M
Loss Per Share -$4.27
Full Income Statement

Balance Sheet

The company has $207.88 million in cash and $5.23 million in debt, with a net cash position of $202.65 million or $4.28 per share.

Cash & Cash Equivalents 207.88M
Total Debt 5.23M
Net Cash 202.65M
Net Cash Per Share $4.28
Equity (Book Value) 161.48M
Book Value Per Share -9.85
Working Capital 174.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$65.73 million and capital expenditures -$2.44 million, giving a free cash flow of -$68.17 million.

Operating Cash Flow -65.73M
Capital Expenditures -2.44M
Depreciation & Amortization 1.38M
Net Borrowing -98,000
Free Cash Flow -68.17M
FCF Per Share -$1.44
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -548.93%
Pretax Margin -516.13%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IAM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -29.12%
FCF Yield -9.80%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IAM has an Altman Z-Score of -1.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.88
Piotroski F-Score 1